Novel Irrigant in Regenerative Endodontics - An In-Vitro Study
Srujana Hemmanur1, Iffat Nasim2*
1 Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.
2 Professor and Head, Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.
*Corresponding Author
Iffat Nasim,
Professor and Head, Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical
and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.
Tel: +919940063567
E-mail: iffatnasim@saveetha.com
Received: May 03, 2021; Accepted: August 11, 2021; Published: August 18, 2021
Citation:Srujana Hemmanur, Iffat Nasim. Novel Irrigant in Regenerative Endodontics- An In-Vitro Study. Int J Dentistry Oral Sci. 2021;8(8):4016-4021. doi: dx.doi.org/10.19070/2377-8075-21000820
Copyright: Iffat Nasim©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction: Regenerative endodontic procedures have gained a limelight in recent times owing to the rates of success that
has been reported by various authors. The potential regeneration of the tissues of the pulp-dentin complex yields us the hope
to bring back the vitality of a non vital tooth. The management of a young permanent tooth with necrotic pulp has remained
a challenge. In the present study, the potential of Farnesol, a sesquiterpene alcohol by origin with a good antimicrobial activity
is tested for cytotoxicity, cell migration and cell proliferation assays against SCAP cells.
Aim: Aim of the study was to evaluate if Farnesol could be used as an irrigant for necrotic immature permanent teeth.
Materials and Methods: 95% Farnesol (Sigma Aldrich, US ) was bought. SCAP cells from Axol Pvt. ltd ( Cambridge, UK)
were derived and a final concentration of 25µM/ml, 50µM/ml and 100µM/ml of the solution was tested on SCAP cells for
the analysis of cytotoxicity, cell migration and cell proliferation. For cytotoxicity evaluation Sulforhodamine Assay, for evaluation
of cell migration Transwell Migration Assay and cell proliferation In-Vitro Bromodeoxyuridine Assay were performed.
Results: Analysis of the results showed statistically significant increase in cytotoxicity with the increase in the final concentration
of Farnesol. Also, reduction in the cell migration and proliferation was seen to significantly decrease with the increasing
concentration of the novel irrigant.
Conclusion: Farnesol at a concentration lower than 25µM/ml, can be tried as a potential irrigant for the management of the
necrotic immature permanent teeth by revascularisation technique. However, clinical studies need to be done to extrapolate
this finding in reality.
2.Introduction
3.Conclusion
4.References
Keywords
Immature Teeth; Necrotic Immature Permanent Teeth (NIPT); Open Spices; Revascularisation.
Introduction
Management of a young permanent tooth with non vital pulp
poses a challenge. The presence of a blunderbuss canal with a
wide apical opening and thin dentinal walls pose the biggest challenge
as inadequate disinfection of the canal space and difficulty
in obturation due to lack of an apical stop is evident [1]. Conventionally,
a necrotic immature permanent tooth is managed by
either apexification using calcium hydroxide or by placing a MTA
apical plug. [2]. These approaches are successful in the long run
as they resolve the clinical signs and symptoms of the disease
but have got no benefits in the improvisation of the root length,
thickness, return of the pulp vitality and nociception etc [3].
Regenerative attempts have not been new to medicine and dentistry.
Iwaya et al and Banchs-Trope have demonstrated the successful
regeneration of an immature tooth with not just the resolution
of disease but also the increase in the length and thickness
of the root and apical closure [4, 5]. Regenerative endodontics are
procedures that are designed to replace damaged tooth structures
and are biologically based [6]. The protocol for the regenerative
endodontic procedures have been formulated based on the findings
of many clinicians. The current protocol that is being followed
has been chalked out by AAE and it has been revised most
recently in 2018. According to the current protocol, in the first
appointment, isolation and pain management is done and disinfection
using copious gentle irrigation of the canal space with a
lower concentration (1.5%) and 20 ml of NaOCl with prevention of its extrusion is performed. A closed dressing with either
calcium hydroxide or TAP or DAP is given and a temporary restorative
material is used to seal the access cavity. The patient is
recalled for the second visit 1-4 weeks after the first and isolation
and LA without vasoconstrictor is used to anesthetize the tooth.
Copious gentle irrigation with 17% EDTA is done and bleeding
is induced by filing beyond the apex. An alternative such as
autologous platelet concentrate can be used and MTA is used as
a capping material. GIC is placed above the capping material and
the access cavity is sealed off. A follow up that consists of a check
for clinical symptoms and radiographic examination is done after
6,12, and 24 months. [7]
The regeneration of the tissue requires three components- stem
cells, scaffolds and growth factors [8]. The absence or late delivery
of any one of the factors would fail the regeneration to occur.
It has been suggested to use the term revitalization instead of
regeneration as the tissue formed in the root canal space is vital
but the nature of which is different from the original lost tissue
[9]. Thus, revascularization as a regenerative modality can shift the
entire paradigm in the management of a young permanent teeth
with necrotic pulp as it can not only resolve the clinical signs and
symptoms but also can aim in the restoration of the tissues in the
root canal space that are of great importance to the clinician and
scientific world.
Previously our team has a rich experience in working on various
research projects across multiple disciplines [10-24] Now the
growing trend in this area motivated us to pursue this project.
Our aim was to check if a novel proposed irrigant like Farnesol
with good antimicrobial properties as checked in in-vitro environment
[25] can be used as a potential irrigant for the management
of the necrotic immature permanent teeth by a relatively newer
technique of revascularization.
Materials and Methods
Stem cells from Apical Papilla (SCAP)
The cryopreserved stem cells from apical papilla (SCAP) (AXOL
bioscience Ltd., UK) was derived and plated at a density of 7x103
cells per well in 96-well plates with DMEM/F12 supplemented
with 10% FBS and 2 mM L-glutamine, 100 UI/ml penicillin and
100 µg/ml streptomycin. Cell growth was assessed by the Neubauer
counting chamber method. Every 24 hours, the cells were
harvested by trypsin EDTA treatment and then were counted
with a hemocytometer. After 72 h, the culture medium was replaced
with a fresh one, and unattached cells were also removed.
When 80-90% confluency was reached, cells were routinely subcultured
and counted using a microscope.
Chemicals
Bromodeoxyuridine, Sulforhodamine, haematoxylin, and other
chemicals were purchased from Rankem laboratories (Ludhiana,
India).
Cytotoxicity test by sulforhodamine assay
The microtiter plates were added with culture medium (DMEM
supplemented with 10% fetal bovine serum, 100 µL/well) was
added and incubated for 24 h at 37 °C in the incubator with 5%
CO2. After 24 h of incubation, cell growth was observed using
a microscope. Cellular concentration used was 1.4 x 104 cells/
mL. Then, the medium was discarded and Farnesol with various
concentrations, negative control and DMEM without fetal bovine
serum were added in each well. After 24 h of incubation, the cells
were fixed with trichloroacetic acid (100 µL/well) and placed under
time and dried. Then the plates were stained for 20 min at
room temperature with SRB 0.4% (50 µL/well). The plates were
washed with 1% acetic acid solution and dried at room temperature.
The unbound dye was removed after washing, the dyestuff
bound to the protein was solubilized in a basic medium to determine
the optical density in a plate reader at 570 nm.
The average absorbance of the negative control (AbsNC), for
each concentration of the tested substances (absT) and positive
control (absPC) was calculated. The percentage of living cells was
given by:
% survival = [(AbsT - AbsNC)/(AbsNC)] x 100
Transwell Migration assay
Cell migration was quantitated using 24-well Transwell inserts (6.5
mm) with polycarbonate filters (5-µm pore size). SCAP cells (0.5
× 106 in 100 µl of RPMI 1640 medium/1% human albumin)
were added to the well. Transwell and 700ml of serum free MEM
with or without Farnesol (25-100µM/ml) was added to the lower
chambers. The plates were incubated at 37°C in 5% CO2 for 24h
and cells remaining on the top of the surface of the filter were
removed with a cotton swab and the cells that had traversed from
the membrane to the bottom chamber were for 10mins with 4%
paraformaldehyde and stained with haematoxylin for 30 mins. To
quantify the migrated cells, 10 random microscopic fields per filter
at 200x magnification were selected for a cell count measurement
were done in triplicates and results calculated as mean in
each experiment.
In vitro Bromodeoxyuridine cell proliferation Assay
A 10 mM stock solution of BrdU was prepared by dissolving 3
mg of BrdU in 1 mL water. The 10 mM BrdU stock solution in
cell culture medium was diluted to make a 10 µM BrdU labeling
solution. SCAP (2500-100000 cells/well) in 100 µl medium were
plated in 96-well plate and incubated with the respective test substance
Farnesol (25, 50 and 100 µM/ml) for 72 hr. The prepared
solution of BrdU with SCAP cells served as a negative control.
A prepared 10 µl of 10X BrdU solution per well were added.
The cells were placed in an incubator for 24 hr. For suspension
cells, centrifugation of the plate at 300xg for 10 min was done
and then the medium was removed. 100 µl/well of the fixing solution
was added to each well at room temperature for 30 min.
Then after the solution was removed, 100 µl/well prepared 1X
detection antibody solution was added and placed at room temperature
for 1 hour. The solution was discarded and the plates
were washed 3 times with 1X Wash Buffer. 100 µl of prepared 1X
HRP-conjugated secondary antibody solution was added in each
well , and incubated at room temperature for 30 min. Then 100
µl TMB Substrate was added and incubated for 30 min at room
temperature, The 100 µl STOP Solution was added and the solution’s absorbance at 450 nm was read.
Statistical Analysis
The experiments were carried out in triplicates, the results were
represented as Mean ± Standard error of mean (SEM). Statistical
differences were determined by one-way analysis of variance
(ANOVA) and post hoc comparison test. P-values <0.05 were
considered statistically signi?cant. Data were analysed using the
SPSS 22.0 package (Chicago, IL, USA).
Results
The Sulforhodamine assay, Transwell migration assay, Bromodeoxyuridine
immunohistochemistry indicated towards the use of
Farnesol as an effective irrigant for necrotic immature permanent
tooth in the in vitro scenario. The concentration of Farnesol at
25µM/ml shows the greatest potential. The graphical representation
of the results have been done in Figures 1,2 and 3 evaluating
cytotoxicity, proliferation and migration of SCAP cells in the
presence of Farnesol at various concentrations respectively.
Figure 1. Graph representing cytotoxicity of SCAP cells: This figure depicts the percentage of cytotoxicity upon treatment with Farnesol . The X axis represents the concentration of Farnesol used for testing and negative control (NC) while the Y axis represents the % of cytotoxicity. Results are represented as a Mean ± SEM of three independent experiments. It can be inferred that least cytotoxicity to SCAP cells is seen when the concentration is 25µM/ml (p value <0.05; statistically significant; One-Way ANOVA).
Figure 2. Graph representing the migration of SCAP cells; This figure depicts the relative migration of SCAP cells upon treatment with Farnesol . The X axis represents the concentration of Farnesol used for testing and negative control (NC) while the Y axis represents the relative migration rate of the SCAP cells. Results are represented as a Mean ± SEM of three independent experiments. It can be inferred that the relative migration rate of SCAP cells is the greatest when 25µM/ml is used as the test agent and the rate decreases with increase in the concentration of Farnesol. (p value <0.05; statistically significant; One-Way ANOVA)
Figure 3. Graph representing the percentage of cell proliferation; This figure depicts the percentage of SCAP proliferation upon treatment with Farnesol .The X axis represents the concentration of Farnesol and negative control (NC) used for testing while the Y axis represents the % of cell proliferation of the SCAP cells. Results are represented as a Mean ± SEM of three independent experiments.It can be inferred from the graph that the SCAP cells proliferate the most when the concentration is 25µM/ml and it decreases with the increase in concentration of Farnesol.(p value <0.05; statistically significant; One-Way ANOVA).
Discussion
Our institution is passionate about high quality evidence based
research and has excelled in various fields [26-36].
The American Association of Endodontists (AAE) identifies the
prospects of regenerative endodontics. Disinfection holds a very
important place in the success of the procedure. Due to the presence
of thin dentinal walls, minimal instrumentation of the canal
must be ensured. The focus of regenerative endodontics has
shifted to proper disinfection. Aurora et al suggested that tissue
healing whether regeneration or repair occurs in a sterile or highly
disinfected environment as the host immune defense system fails
to promote tissue- destruction by inflammatory responsive processes
[37]. Trevino et al, [38] evaluated the survival of SCAP cells
which are supposed to be a source of stem cells in regenerative
endodontic procedures as reported by Sonoyama et al, 2008 [39].
They suggested the use of EDTA promoted greater survival of
SCAP cells and also had the property to reverse effects of sodium
hypochlorite which is used to debride the canal space off necrotic
tissue. Hence. 17% EDTA is recommended to be used as the final
irrigant so as to allow the release of growth factors from dentin
[38].1.5% Sodium hypochlorite has the least effect on the survival
and proliferation of SCAP cells and hence it was used in copious
amounts for irrigation [40].
.
The use of calcium hydroxide as an intracanal medicament has
been suggested as it is non discolouring, can be easily removed
from the canal space and has no detrimental effect on the survival
of SCAP which is not seen when TAP was used [41].
Farnesol is a natural product that structurally exists as a sesquiterpene
alcohol commonly found in propolis and essential oils
of citrus fruits. The antimicrobial and anti-biofilm activity of
Farnesol has attracted the attention of researchers in recent times.
Farnesol was seen to affect the biomass and biofilm composition of dual species biofilm. It also effectively blocks the quorum
sensing amongst multi-species biofilm which helps in fighting the
resistance [25, 42-44] . An in-vivo evaluation of Ti6Al4V implants
treated with Farnesol has shown a decreased rate of colonisation
of S.aureus and the dental implant commonly used is of the same
composition [45]. Farnesol has suggested an effective induced
cell cycle arrest and apoptosis of tumor cells in carcinoma like
pancreatic cancer [46, 47]. Farnesol by preventing the conversion
of fungi to hyphae seems to decrease the pathogenicity of vulvovaginal
candidiasis [48] and oral candidiasis in mice [49]. Farnesol
is also reported to have low cytotoxic effects and no genotoxicity
towards fibroblasts [44].
Given the wide array of use of Farnesol, antimicrobial nature
and low cytotoxicity and genotoxic effects of Farnesol, current
study was designed to check if Farnesol can effectively be used as
an irrigant for necrotic immature permanent teeth ,based on the
results of in-vitro analysis done by Andrade et al, 2017 in which
they suggested that it can be used as a potential irrigant for root
canal treatment [44].
The Sulforhodamine assay was developed by Skehan and colleagues
in 1990 for anticancer drug screening [50]. It is a colorimetric
technique, with results as sensitive as obtained from other
cytotoxicity assays like the MTT. This assay is based on the ability
of a protein dye ( sulforhodamine B) to bind electrostatically to
the basic protein amino acid residues of acetic acid fixed cells
[51]. The cytotoxic effect of Farnesol on SCAP cells can be seen
to be increasing with an increase in the concentration. The least
cytotoxic effect was seen when Farnesol at a concentration of
25µM/ml was used as the test product (Figure 1).
Transwell migration assay provides an analysis to check for the
ability of a particular group of cells to sense the presence of a
chemoattractant and to migrate towards it through a physical barrier
that is present [52]. In this study, the migration of SCAP in
the presence of Farnesol was checked as without the migration of
the stem cells to the canal space, the regeneration cannot occur.
The number of migrated cells was quantified by counting them
underneath a microscope or by taking pictures and evaluating
them. The chemotaxis and directional cell migration of any group
of cells in an in-vitro setup can be checked through this assay. In
the present study, greatest amounts of cell migration was appreciated
when Farnesol in the concentration of 25µM/ml was used
as the test product. The relationship between the cell migration
and concentration of farnesol can thus be considered as inversely
proportional, with the least migration in higher concentration of
the product (Figure 2).
Bromodeoxyuridine immunohistochemistry in the 1980s was
used to examine the proliferation and migration of cells of CNS
[53]. BrdU competes with thymidine and gets incorporated into
the nuclear DNA. The presence of BrdU marks DNA synthesis
and this DNA when fixed, incubated and treated with anti-BrdU
monoclonal antibodies produce a colorimetric reaction when the
secondary antibody gets exposed to an added substrate. This can
be visualised under a microscope [54]. In the present study, maximum
proliferation of SCAP was seen when Farnesol was used in
the concentration of 25µM/ml (Fig.3). As the concentration of
Farnesol increased, the rate of proliferation of SCAP cells was
seen to decrease.
With the current study, a concentration of 25µM/ml of Farnesol
may be tried to be used as a potential irrigant for regenerative endodontics
as it not only provides good antimicrobial efficacy and
the cyotoxicity, cell migration and proliferation of SCAP is seen
under in-vitro conditions.
Although Regenerative endodontic procedures have provided
clinical success, the tissue formed in the pulp canal space is of
varying nature. Hence, the regeneration of the tissues still remain
bleak and it is the repair that is being induced. More advanced
bioengineering approaches may in future lead to the achieving of
predictable regeneration of vital and natural pulp-like tissue.
Conclusion
Farnesol 95% ( Sigma Aldrich, US ) at a concentration of about
25µM/ml, can be used as a potential irrigant for the management
of the necrotic immature permanent teeth by revascularization
technique. However, clinical studies need to be done to extrapolate
this finding in reality.
References
-
[1]. Suwal P. ‘General Systemic Evaluation of Prosthodontic Patients: A Literature
Review’, 2013;13(2):90–94.
[2]. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005 Nov 19;366(9499):1809-20.
[3]. Mootha A, Malaiappan S, Jayakumar ND, Varghese SS, Toby Thomas J. The Effect of Periodontitis on Expression of Interleukin-21: A Systematic Review. Int J Inflam. 2016;2016:3507503.Pubmed PMID: 26998377.
[4]. Varghese SS, Thomas H, Jayakumar ND, Sankari M, Lakshmanan R. Estimation of salivary tumor necrosis factor-alpha in chronic and aggressive periodontitis patients. Contemp Clin Dent. 2015 Sep;6(Suppl 1):S152-6. Pubmed PMID: 26604566.
[5]. Ramesh A, Varghese SS, Jayakumar ND, Malaiappan S. Chronic obstructive pulmonary disease and periodontitis–unwinding their linking mechanisms. J. Oral Biosci. 2016 Feb 1;58(1):23-6.
[6]. Priyanka S, Kaarthikeyan G, Nadathur JD, Mohanraj A, Kavarthapu A. Detection of cytomegalovirus, Epstein-Barr virus, and Torque Teno virus in subgingival and atheromatous plaques of cardiac patients with chronic periodontitis. J Indian Soc Periodontol. 2017 Nov-Dec;21(6):456-460.Pubmed PMID: 29551863.
[7]. Foz AM, Artese HP, Horliana AC, Pannuti CM, Romito GA. Occlusal adjustment associated with periodontal therapy--a systematic review. J Dent. 2012 Dec;40(12):1025-35.Pubmed PMID: 22982113.
[8]. Herrera D, Roldán S, González I, Sanz M. The periodontal abscess (I). Clinical and microbiological findings. J Clin Periodontol. 2000 Jun;27(6):387- 94.
[9]. Khalid W, Vargheese SS, Lakshmanan R, Sankari M, Jayakumar ND. Role of endothelin-1 in periodontal diseases: A structured review. Indian J Dent Res. 2016 May-Jun;27(3):323-33.Pubmed PMID: 27411664.
[10]. Khalid W, Varghese SS, Sankari M, Jayakumar ND. Comparison of Serum Levels of Endothelin-1 in Chronic Periodontitis Patients Before and After Treatment. J Clin Diagn Res. 2017 Apr;11(4):ZC78-ZC81.Pubmed PMID: 28571268.
[11]. Avinash K, Malaippan S, Dooraiswamy JN. Methods of Isolation and Characterization of Stem Cells from Different Regions of Oral Cavity Using Markers: A Systematic Review. Int J Stem Cells. 2017 May 30;10(1):12-20. Pubmed PMID: 28531913.
[12]. Ramamurthy JA, Mg V. Comparison of effect of Hiora mouthwash versus Chlorhexidine mouthwash in gingivitis patients: A clinical trial. Asian J Pharm Clin Res. 2018 Jul 7;11(7):84-8.
[13]. Nyman SR, Lang NP. Tooth mobility and the biological rationale for splinting teeth. Periodontol 2000. 1994 Feb;4(1):15-22.
[14]. Nyman S, Lindhe J. Persistent tooth hypermobility following completion of periodontal treatment. J Clin Periodontol. 1976 May;3(2):81-93.Pubmed PMID: 1064597.
[15]. Mühlemann HR. Tooth Mobility: The Measuring Method. Initial and Secondary Tooth Mobility. J Periodontol. 1954 Jan;25(1):22–9.
[16]. Schulte W, d'Hoedt B, Lukas D, Maunz M, Steppeler M. Periotest for measuring periodontal characteristics--correlation with periodontal bone loss. J Periodontal Res. 1992 May;27(3):184-90.Pubmed PMID: 1608031.
[17]. Castellini P, Scalise L, Tomasini EP. Teeth mobility measurement: a laser vibrometry approach. J Clin Laser Med Surg. 1998 Oct;16(5):269-72.Pubmed PMID: 9893508.
[18]. Goellner M, Berthold C, Holst S, Wichmann M, Schmitt J. Correlations between photogrammetric measurements of tooth mobility and the Periotest method. Acta Odontol Scand. 2012 Jan;70(1):27-35.Pubmed PMID: 21504267. [19]. Mühlemann HR. 10 years of tooth-mobility measurements. J. Periodontol. 1960 Apr;31(2):110-22. [20]. Persson R. Assessment of tooth mobility using small loads. II. Effect of oral hygiene procedures. J Clin Periodontol. 1980 Dec;7(6):506-15.Pubmed PMID: 7012187.
[21]. Persson R. Assessment of tooth mobility using small loads. III. Effect of periodontal treatment including a gingivectomy procedure. J Clin Periodontol. 1981 Feb;8(1):4-11.Pubmed PMID: 6941976.
[22]. Serio FG. Clinical rationale for tooth stabilization and splinting. Dent Clin North Am. 1999 Jan 1;43(1):1-6.
[23]. Forabosco A, Grandi T, Cotti B. The importance of splinting of teeth in the therapy of periodontitis. Minerva Stomatol. 2006 Mar;55(3):87-97.Pubmed PMID: 16575381.
[24]. Thamaraiselvan M, Elavarasu S, Thangakumaran S, Gadagi JS, Arthie T. Comparative clinical evaluation of coronally advanced flap with or without platelet rich fibrin membrane in the treatment of isolated gingival recession. J Indian Soc Periodontol. 2015 Jan;19(1):66.
[25]. Ravi S, Malaiappan S, Varghese S, Jayakumar ND, Prakasam G. Additive Effect of Plasma Rich in Growth Factors With Guided Tissue Regeneration in Treatment of Intrabony Defects in Patients With Chronic Periodontitis: A Split-Mouth Randomized Controlled Clinical Trial. J Periodontol. 2017 Sep;88(9):839-845.Pubmed PMID: 28474968.
[26]. Panda S, Jayakumar ND, Sankari M, Varghese SS, Kumar DS. Platelet rich fibrin and xenograft in treatment of intrabony defect. Contemp Clin Dent. 2014 Oct;5(4):550.
[27]. Ramesh A, Ravi S, Kaarthikeyan G. Comprehensive rehabilitation using dental implants in generalized aggressive periodontitis. J Indian Soc Periodontol. 2017 Mar;21(2):160.
[28]. Kavarthapu A, Thamaraiselvan M. Assessing the variation in course and position of inferior alveolar nerve among south Indian population: A cone beam computed tomographic study. Indian J Dent Res. 2018 Jul- Aug;29(4):405-409.Pubmed PMID: 30127186.
[29]. Ramesh A, Vellayappan R, Ravi S, Gurumoorthy K. Esthetic lip repositioning: A cosmetic approach for correction of gummy smile - A case series. J Indian Soc Periodontol. 2019 May-Jun;23(3):290-294.Pubmed PMID: 31143013.
[30]. Ramesh A, Varghese SS, Doraiswamy JN, Malaiappan S. Herbs as an antioxidant arsenal for periodontal diseases. J Intercult Ethnopharmacol. 2016 Jan 27;5(1):92-6.Pubmed PMID: 27069730.
[31]. Soares PB, Fernandes Neto AJ, Magalhăes D, Versluis A, Soares CJ. Effect of bone loss simulation and periodontal splinting on bone strain: Periodontal splints and bone strain. Arch Oral Biol. 2011 Nov;56(11):1373-81.Pubmed PMID: 21550587.
[32]. Jain AR. Prevalence of partial edentulousness and treatment needs in rural population of South India. World J. Dent. 2017 Jun;8(3):213-7.
[33]. Varghese SS, Ramesh A, Veeraiyan DN. Blended Module-Based Teaching in Biostatistics and Research Methodology: A Retrospective Study with Postgraduate Dental Students. J Dent Educ. 2019 Apr;83(4):445-450.Pubmed PMID: 30745352.
[34]. Ashok V, Ganapathy D. A geometrical method to classify face forms. J Oral Biol Craniofac Res. 2019 Jul 1;9(3):232-5.
[35]. Padavala S, Sukumaran G. Molar incisor hypomineralization and its prevalence. Contemp. Clin. Dent. 2018 Sep;9(Suppl 2):S246-50.
[36]. Ke Y, Al Aboody MS, Alturaiki W, Alsagaby SA, Alfaiz FA, Veeraraghavan VP, et al. Photosynthesized gold nanoparticles from Catharanthus roseus induces caspase-mediated apoptosis in cervical cancer cells (HeLa). Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1938-1946.Pubmed PMID: 31099261.
[37]. Ezhilarasan D. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab J Gastroenterol. 2018 Jun;19(2):56-64.Pubmed PMID: 29853428. [38]. Krishnan RP, Ramani P, Sherlin HJ, Sukumaran G, Ramasubramanian A, Jayaraj G, et al. Surgical Specimen Handover from Operation Theater to Laboratory: A Survey. Ann Maxillofac Surg. 2018 Jul-Dec;8(2):234-238. Pubmed PMID: 30693238.
[39]. Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):192-197.Pubmed PMID: 29709350.
[40]. Pandian KS, Krishnan S, Kumar SA. Angular photogrammetric analysis of the soft-tissue facial profile of Indian adults. Indian J. Dent. Res. 2018 Mar 1;29(2):137-43.
[41]. Ramamurthy JA, Mg V. Comparison of effect of Hiora mouthwash versus Chlorhexidine mouthwash in gingivitis patients: A clinical trial. Asian J Pharm Clin Res. 2018 Jul 7;11(7):84-8.
[42]. Gupta P, Ariga P, Deogade SC. Effect of Monopoly-coating Agent on the Surface Roughness of a Tissue Conditioner Subjected to Cleansing and Disinfection: A Contact Profilometric In vitro Study. Contemp Clin Dent. 2018 Jun;9(Suppl 1):S122-S126.Pubmed PMID: 29962776.
[43]. Vikram NR, Prabhakar R, Kumar SA, Karthikeyan MK, Saravanan R. Ball Headed Mini Implant. J Clin Diagn Res. 2017 Jan;11(1):ZL02-3.
[44]. Paramasivam A, Vijayashree Priyadharsini J, Raghunandhakumar S. N6- adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases. Hypertens Res. 2020 Feb;43(2):153- 154.Pubmed PMID: 31578458.
[45]. Palati S, Ramani P, Shrelin HJ, Sukumaran G, Ramasubramanian A, Don KR, et al. Knowledge, Attitude and practice survey on the perspective of oral lesions and dental health in geriatric patients residing in old age homes. Indian J Dent Res. 2020 Jan-Feb;31(1):22-25.Pubmed PMID: 32246676.
[46]. Samuel SR, Acharya S, Rao JC. School Interventions-based Prevention of Early-Childhood Caries among 3-5-year-old children from very low socioeconomic status: Two-year randomized trial. J Public Health Dent. 2020 Jan;80(1):51-60.Pubmed PMID: 31710096.
[47]. Ebeleseder KA, Glockner K, Pertl C, Städtler P. Splints made of wire and composite: an investigation of lateral tooth mobility in vivo. Endod Dent Traumatol. 1995 Dec;11(6):288-93.Pubmed PMID: 8617165.
[48]. Kumbuloglu O, Saracoglu A, Ozcan M. Pilot study of unidirectional E-glass fibre-reinforced composite resin splints: up to 4.5-year clinical follow-up. J Dent. 2011 Dec;39(12):871-7.Pubmed PMID: 22001066.
[49]. Sekhar LC, Koganti VP, Shankar BR, Gopinath A. A comparative study of temporary splints: bonded polyethylene fiber reinforcement ribbon and stainless steel wire + composite resin splint in the treatment of chronic periodontitis. J Contemp Dent Pract. 2011 Sep 1;12(5):343-9.Pubmed PMID: 22269194.
[50]. Bhawna G. Burden of smoked and smokeless tobacco consumption in India - results from the Global adult Tobacco Survey India (GATS-India)- 2009-2010. Asian Pac J Cancer Prev. 2013;14(5):3323-9.Pubmed PMID: 23803124.
[51]. Kinane DF, Chestnutt IG. Smoking and periodontal disease. Crit Rev Oral Biol Med. 2000 Jul;11(3):356-65.
[52]. Sobouti F, Rakhshan V, Saravi MG, Zamanian A, Shariati M. Two-year survival analysis of twisted wire fixed retainer versus spiral wire and fiberreinforced composite retainers: a preliminary explorative single-blind randomized clinical trial. Korean J Orthod. 2016 Mar;46(2):104-10.Pubmed PMID: 27019825.
[53]. Akcali A, Gümüs P, Özcan M. Clinical comparison of fiber-reinforced composite and stainless steel wire for splinting periodontally treated mobile teeth. Braz. Dent. Sci. 2014 Aug 25;17(3):39-49.
[54]. Vijayashree Priyadharsini J. In silico validation of the non-antibiotic drugs acetaminophen and ibuprofen as antibacterial agents against red complex pathogens. J Periodontol. 2019 Dec;90(12):1441-1448.Pubmed PMID: 31257588.
[55]. Pc J, Marimuthu T, Devadoss P, Kumar SM. Prevalence and measurement of anterior loop of the mandibular canal using CBCT: A cross sectional study. Clin Implant Dent Relat Res. 2018 Apr 6;20(4):531-4.
[56]. Ramesh A, Varghese S, Jayakumar ND, Malaiappan S. Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. J Periodontol. 2018 Oct;89(10):1241-1248.Pubmed PMID: 30044495.
[57]. Ramadurai N, Gurunathan D, Samuel AV, Subramanian E, Rodrigues SJ. Effectiveness of 2% Articaine as an anesthetic agent in children: randomized controlled trial. Clin Oral Investig. 2019 Sep;23(9):3543-50.
[58]. Sridharan G, Ramani P, Patankar S, Vijayaraghavan R. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med. 2019 Apr;48(4):299-306.
[59]. Ezhilarasan D, Apoorva VS, Ashok Vardhan N. Syzygium cumini extract induced reactive oxygen species-mediated apoptosis in human oral squamous carcinoma cells. J Oral Pathol Med. 2019 Feb;48(2):115-121.Pubmed PMID: 30451321.
[60]. Mathew MG, Samuel SR, Soni AJ, Roopa KB. Evaluation of adhesion of Streptococcus mutans, plaque accumulation on zirconia and stainless steel crowns, and surrounding gingival inflammation in primary molars: randomized controlled trial. Clin Oral Investig. 2020 Sep;24(9):1-6.Pubmed PMID: 31955271.
[61]. Samuel SR. Can 5-year-olds sensibly self-report the impact of developmental enamel defects on their quality of life? Int J Paediatr Dent. 2021 Mar;31(2):285-286.Pubmed PMID: 32416620.
[62]. R H, Ramani P, Ramanathan A, R JM, S G, Ramasubramanian A, et al. CYP2 C9 polymorphism among patients with oral squamous cell carcinoma and its role in altering the metabolism of benzo[a]pyrene. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Sep;130(3):306-312.Pubmed PMID: 32773350.
[63]. Chandrasekar R, Chandrasekhar S, Sundari KKS, Ravi P. Development and validation of a formula for objective assessment of cervical vertebral bone age. Prog Orthod. 2020 Oct 12;21(1):38.Pubmed PMID: 33043408.
[64]. Vijayashree Priyadharsini J, Smiline Girija AS, Paramasivam A. In silico analysis of virulence genes in an emerging dental pathogen A. baumannii and related species. Arch Oral Biol. 2018 Oct;94:93-98.Pubmed PMID: 30015217.